| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| Aridis Pharmaceuticals (ARDS) | Cantor | $34.50 | n.a. | |||
| Megalith Financial Acquisition (MFACU) (u) | Chardan | 15.00 | $10.00 | $10.00 | $150.00 | n.a. |
| Pintec Technology Holdings (PT) | Goldman Sachs (Asia)/ Deutsche Bank Securities/ Citigroup | $70.00 | n.a. | |||
| Ra Medical (RMED) | Piper Jaffray/ Cantor | $86.25 | n.a. | |||
| Spartan Energy Acquisition (SPAQ) (u) | Citigroup/ Credit Suisse | 40.00 | $10.00 | $10.00 | $400.00 | n.a. |
| Tenzing Acquisition (TZACU) (u) | Maxim Group | 5.00 | $10.00 | $10.00 | $50.00 | n.a. |
| n.a. (not available) | ||||||
| u (unit offering) | ||||||
| Postponed | ||||||
| AFG Holdings (AFGL) | Goldman Sachs/ Credit Suisse/ Simmons & Company International (Energy Specialists of Piper Jaffray)/ Barclays/ Citigroup/ Evercore ISI/ Wells Fargo Securities | 18.20 | $15.00 | $18.00 | $300.30 | 1-Star |
| Withdrawn | ||||||
| Molino Cañuelas S.A.C.I.F.I.A. (MOLC) | BofA Merrill Lynch/ J.P. Morgan/ UBS Investment Bank | $100.00 | n.a. | |||
| New Terms | ||||||
| Aquestive Therapeutics (AQST) | BMO Capital Markets/ RBC Capital Markets | 4.00 | $14.00 | $16.00 | $60.00 | S/O |
| Berry Petroleum (BRY) | Goldman Sachs/ Wells Fargo Securities/ BMO Capital Markets | 18.75 | $15.00 | $17.00 | $300.00 | S/O |
| Bionano Genomics (BNGO) | Roth Capital Partners | 3.35 | $8.00 | $10.00 | $30.15 | S/O |
| Cango (CANG) | Morgan Stanley/ BofA Merrill Lynch/ Goldman Sachs (Asia) | 12.50 | $10.00 | $12.00 | $137.50 | S/O |
| Endava (DAVA) | Morgan Stanley/ Citigroup/ Credit Suisse/ Deutsche Bank Securities | 5.60 | $17.00 | $19.00 | $100.80 | S/O |
| Focus Financial Partners (FOCS) | Goldman Sachs/ BofA Merrill Lynch/ KKR/ BMO Capital Markets/ RBC Capital Markets/ SunTrust Robinson Humphrey | 16.22 | $35.00 | $39.00 | $600.00 | S/O |
| MR2 Group (MRMR) | ThinkEquity (A division of Fordham Financial Management) | 1.84 | $7.00 | $9.00 | S/O | |
| Pinduoduo (PDD) | Credit Suisse/ Goldman Sachs (Asia)/ CICC | 85.60 | $16.00 | $19.00 | $1,498.00 | S/O |
| Tenable Holdings (TENB) | Morgan Stanley/ J.P. Morgan/ Allen & Company/ Deutsche Bank Securities | 9.20 | $17.00 | $19.00 | $165.60 | S/O |
| S/O | ||||||
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of July 16, 2018 | Manager(s) | Offered | Raised | Price | 7/20/18 | Change |
| Allakos (ALLK) | Goldman Sachs/ Jefferies | 7.13 | $128.40 | $18.00 | $35.05 | 94.72% |
| Tilray (TLRY) | Cowen and Company | 9.00 | $153.00 | $17.00 | $29.77 | 75.12% |
| Establishment Labs Holdings (ESTA) | Jefferies/ Cowen | 3.72 | $66.87 | $18.00 | $26.39 | 46.61% |
| Crinetics Pharmaceuticals (CRNX) | J.P. Morgan/ Leerink Partners/ Piper Jaffray | 6.00 | $102.00 | $17.00 | $23.00 | 35.29% |
| Rubius Therapeutics (RUBY) | J.P. Morgan/ Morgan Stanley/ Jefferies/ Leerink Partners | 10.49 | $241.18 | $23.00 | $26.54 | 15.39% |
| Coastal Financial (CCB) | Keefe, Bruyette & Woods (A Stifel Company)/ Hovde Group | 2.85 | $41.33 | $14.50 | $15.78 | 8.83% |
| Replimune Group (REPL) | J.P. Morgan/ Leerink Partners/ BMO Capital Market | 6.70 | $100.50 | $15.00 | $15.16 | 1.07% |
| First Western Financial (MYFW) | Keefe, Bruyette & Woods (A Stifel Company)/ Stephens | 1.98 | $37.53 | $19.00 | $19.10 | 0.53% |
| Constellation Pharmaceuticals (CNST) | J.P. Morgan/ Jefferies/ BMO Capital Markets | 4.00 | $60.00 | $15.00 | $11.89 | -20.73% |
